ClinicalTrials.Veeva

Menu

The Effect of a Dietary Supplement Rich in Nitric Oxide in Patients Diagnosed With Primary Ciliary Dyskinesia.

The University of Texas System (UT) logo

The University of Texas System (UT)

Status

Enrolling

Conditions

Primary Ciliary Dyskinesia

Treatments

Dietary Supplement: Beet-it Juice

Study type

Interventional

Funder types

Other

Identifiers

NCT04489472
HSC-MS-19-0382

Details and patient eligibility

About

The purpose of this study is to determine the effect of a dietary supplement rich in nitric oxide (NO) on nasal nitric oxide and fractional exhaled nitric oxide (FeNO),on ciliary beat frequency assessed by high-speed digital video microscopy and on lung function assessed by spirometry in normal patients and patients with Primary ciliary dyskinesia (PCD).

Enrollment

20 estimated patients

Sex

All

Ages

4 to 99 years old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

Experimental group:

  • PCD patients

Control Group:

  • patients with no known chronic lung disease
  • 18 years to 99 years

Exclusion Criteria(both PCD patients and control group):

  • any other pulmonary co-morbidities and diseases entities like cystic fibrosis, nasal sinus surgery, nasal sinus hypoplasia/aplasia, deviated nasal septum, nasal polyps and with upper respiratory tract infection
  • patients allergic to beet
  • a known prolonged bleeding disorder.

Trial design

Primary purpose

Treatment

Allocation

Non-Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

20 participants in 2 patient groups, including a placebo group

PCD Group
Experimental group
Treatment:
Dietary Supplement: Beet-it Juice
Control Group
Placebo Comparator group
Treatment:
Dietary Supplement: Beet-it Juice

Trial contacts and locations

1

Loading...

Central trial contact

Diana Castillo; Ricardo A Mosquera, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems